The Centre for Health Protection today said it is investigating three additional imported COVID-19 cases involving patients who arrived from Israel, Japan and Qatar.
One of them, a 36-year-old woman, lives in Tung Shun Hing Building, 22 Chi Kiang Street in To Kwa Wan and received two doses of the BioNTech vaccine in June and July in Hong Kong.
She tested negative in Hong Kong on August 21 and travelled to Nigeria on August 22. She returned on September 10 by flight QR818, and her specimen collected upon arrival tested positive for COVID-19 and carried the L452R mutant strain.
She works at 28/F, Lee & Man Commercial Centre in North Point, and was last there on August 21.
Epidemiological investigation and contact tracing are ongoing. As a precaution, the building where the patient resided and worked during the incubation period have been included in a compulsory testing notice. Specified people who had been present at the relevant venues at specified periods must undergo compulsory testing by tomorrow.
The Department of Health reminded specified people linked to Tower 2, Phase 2A – Le Prestige, LOHAS Park in Tseung Kwan O and Hong Kin House, Tsz Hong Estate in Tsz Wan Shan to undergo compulsory testing tomorrow.
The Government will set up a mobile specimen collection station at the Podium near Tower 2, Level 6, Phase 2A – Le Prestige tomorrow, and the one at the open area outside Hong Kin House will keep operating tomorrow to provide free testing service for those subject to compulsory testing.
A total of 47 cases were reported in Hong Kong in the past 14 days, all of which are imported.
For information and health advice on COVID-19, visit the Government’s dedicated webpage.